LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Fishery resource management with migratory prey harvesting in two zones- delay and stochastic approach.

    Niranjan, H / Srinivas, M N / Murty, A V S N / Viswanathan, K K

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 7273

    Abstract: In this work, we looked at a two-zone aquatic habitat where both prey and predators can access the zones. The prey alternates between two zones at random. The growth of prey in the absence of a predator is believed to be logistic in each zone. The inner ... ...

    Abstract In this work, we looked at a two-zone aquatic habitat where both prey and predators can access the zones. The prey alternates between two zones at random. The growth of prey in the absence of a predator is believed to be logistic in each zone. The inner steady state is determined. Around the interior steady state, the deterministic model's local and global stability is investigated. Furthermore, a stochastic stability study is performed in the neighbourhood of a positive steady state, using analytical estimates of population mean square fluctuations to investigate the system's dynamics in the presence of Gaussian white noise.
    Language English
    Publishing date 2023-05-04
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-34130-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: SARS-CoV-2 infection among healthcare workers in India: Limitations of the case-control investigation.

    Niranjan, Viswanathan / Kinnersley, Nelson

    The Indian journal of medical research

    2020  Volume 152, Issue 1 & 2, Page(s) 143–144

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Health Personnel ; Humans ; India ; Pandemics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome/epidemiology
    Keywords covid19
    Language English
    Publishing date 2020-08-10
    Publishing country India
    Document type Letter ; Comment
    ZDB-ID 390883-5
    ISSN 0971-5916 ; 0019-5340
    ISSN 0971-5916 ; 0019-5340
    DOI 10.4103/ijmr.IJMR_2360_20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: SARS-CoV-2 infection among healthcare workers in India

    Viswanathan Niranjan / Nelson Kinnersley

    Indian Journal of Medical Research, Vol 152, Iss 1, Pp 143-

    Limitations of the case-control investigation

    2020  Volume 144

    Keywords Medicine ; R ; covid19
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Wolters Kluwer Medknow Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: SARS-CoV-2 infection among healthcare workers in India

    Niranjan, Viswanathan / Kinnersley, Nelson

    Indian Journal of Medical Research

    Limitations of the case-control investigation

    2020  Volume 152, Issue 1, Page(s) 143

    Keywords General Biochemistry, Genetics and Molecular Biology ; General Medicine ; covid19
    Language English
    Publisher Medknow
    Publishing country in
    Document type Article ; Online
    ZDB-ID 390883-5
    ISSN 0019-5340 ; 0971-5916
    ISSN 0019-5340 ; 0971-5916
    DOI 10.4103/ijmr.ijmr_2360_20
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants.

    Abiramalatha, Thangaraj / Thomas, Niranjan / Gupta, Vijay / Viswanathan, Anand / McGuire, William

    The Cochrane database of systematic reviews

    2017  Volume 9, Page(s) CD012413

    Abstract: Background: Breast milk alone, given at standard recommended volumes (150 to 180 mL/kg/d), is not adequate to meet the protein, energy, and other nutrient requirements of growing preterm or low birth weight infants. One strategy that may be used to ... ...

    Abstract Background: Breast milk alone, given at standard recommended volumes (150 to 180 mL/kg/d), is not adequate to meet the protein, energy, and other nutrient requirements of growing preterm or low birth weight infants. One strategy that may be used to address these potential nutrient deficits is to give infants enteral feeds in excess of 200 mL/kg/d ('high-volume' feeds). This approach may increase nutrient uptake and growth rates, but concerns include that high-volume enteral feeds may cause feed intolerance, gastro-oesophageal reflux, aspiration pneumonia, necrotising enterocolitis, or complications related to fluid overload, including patent ductus arteriosus and bronchopulmonary dysplasia.
    Objectives: To assess the effect on growth and safety of feeding preterm or low birth weight infants with high (> 200 mL/kg/d) versus standard (≤ 200 mL/kg/d) volume of enteral feeds. Infants in intervention and control groups should have received the same type of milk (breast milk, formula, or both), the same fortification or micronutrient supplements, and the same enteral feeding regimen (bolus, continuous) and rate of feed volume advancement.To conduct subgroup analyses based on type of milk (breast milk vs formula), gestational age or birth weight category of included infants (very preterm or VLBW vs preterm or LBW), presence of intrauterine growth restriction (using birth weight relative to the reference population as a surrogate), and income level of the country in which the trial was conducted (low or middle income vs high income) (see 'Subgroup analysis and investigation of heterogeneity').
    Search methods: We used the Cochrane Neonatal standard search strategy, which included searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2) in the Cochrane Library; MEDLINE (1946 to November 2016); Embase (1974 to November 2016); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to November 2016), as well as conference proceedings, previous reviews, and trial registries.
    Selection criteria: Randomised and quasi-randomised controlled trials that compared high-volume versus standard-volume enteral feeds for preterm or low birth weight infants.
    Data collection and analysis: Two review authors assessed trial eligibility and risk of bias and independently extracted data. We analysed treatment effects in individual trials and reported the risk ratio and risk difference for dichotomous data, and the mean difference for continuous data, with respective 95% confidence intervals. . We assessed the quality of evidence at the outcome level via the GRADE approach.
    Main results: We found one eligible trial that included 64 infants. This trial was not blinded. Analysis showed a higher rate of weight gain in the high-volume feeds group: mean difference 6.20 g/kg/d (95% confidence interval 2.71 to 9.69). There was no increase in the risk of feed intolerance or necrotising enterocolitis with high-volume feeds, but 95% confidence intervals around these estimates were wide. We assessed the quality of evidence for these outcomes as 'low' or 'very low' because of imprecision of the estimates of effect and concern about risk of bias due to lack of blinding in the included trial. Trial authors provided no data on other outcomes, including gastro-oesophageal reflux, aspiration pneumonia, necrotising enterocolitis, patent ductus arteriosus, bronchopulmonary dysplasia, or long-term growth and neurodevelopment.
    Authors' conclusions: We found only very limited data from one small unblinded trial on the effects of high-volume feeds on important outcomes for preterm or low birth weight infants. The quality of evidence is low to very low. Hence, available evidence is insufficient to support or refute high-volume enteral feeds in preterm or low birth weight infants. A large, pragmatic randomised controlled trial is needed to provide data of sufficient quality and precision to inform policy and practice.
    Language English
    Publishing date 2017-09-12
    Publishing country England
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 1469-493X
    ISSN (online) 1469-493X
    DOI 10.1002/14651858.CD012413.pub2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Preparation and characterization of silver nanoparticle loaded amorphous hydrogel of carboxymethylcellulose for infected wounds.

    Das, Anup / Kumar, Ajay / Patil, Niranjan B / Viswanathan, Chandra / Ghosh, Deepa

    Carbohydrate polymers

    2015  Volume 130, Page(s) 254–261

    Abstract: There is a growing demand for an appropriate and safe antimicrobial dressing to treat infected deep wounds. An amorphous gel formulation (SNP-CMC), containing silver nanoparticles (SNPs) and carboxymethylcellulose (CMC), was prepared in one step by the ... ...

    Abstract There is a growing demand for an appropriate and safe antimicrobial dressing to treat infected deep wounds. An amorphous gel formulation (SNP-CMC), containing silver nanoparticles (SNPs) and carboxymethylcellulose (CMC), was prepared in one step by the reduction of silver nitrate in situ. Spectrophotometric and microscopic analysis revealed that the SNPs were 7-21 nm in diameter. In simulated wound experiments, SNP-CMC gel was found to absorb 80.48 ± 4.69% w/w of saline and donate 17.43 ± 0.76% w/w of moisture within 24h indicating its dual fluid affinity. Cytocompatibility of the gel was assessed by proliferation studies with primary human skin cells. The antimicrobial activity studies showed that SNP-CMC containing 50 ppm of SNPs was effective against the growth of both Gram negative and Gram positive strains including methicillin-resistant Staphylococcus aureus (MRSA). These results indicate that SNP-CMC could be ideal for the treatment of deep infected wounds.
    MeSH term(s) Anti-Bacterial Agents/chemical synthesis ; Anti-Bacterial Agents/pharmacology ; Bandages ; Carboxymethylcellulose Sodium/chemistry ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cells, Cultured ; Dermis/cytology ; Dermis/drug effects ; Fibroblasts/cytology ; Fibroblasts/drug effects ; Humans ; Hydrogels/chemistry ; Hydrogels/pharmacology ; Keratinocytes/cytology ; Keratinocytes/drug effects ; Laxatives/chemistry ; Metal Nanoparticles/chemistry ; Methicillin-Resistant Staphylococcus aureus/drug effects ; Methicillin-Resistant Staphylococcus aureus/isolation & purification ; Silver/chemistry ; Staphylococcal Infections/drug therapy ; Staphylococcal Infections/microbiology ; Wound Healing/drug effects ; Wound Infection/drug therapy
    Chemical Substances Anti-Bacterial Agents ; Hydrogels ; Laxatives ; Silver (3M4G523W1G) ; Carboxymethylcellulose Sodium (K679OBS311)
    Language English
    Publishing date 2015-10-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1501516-6
    ISSN 1879-1344 ; 0144-8617
    ISSN (online) 1879-1344
    ISSN 0144-8617
    DOI 10.1016/j.carbpol.2015.03.082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.

    Donner, Barbara / Niranjan, Viswanathan / Hoffmann, Gerhard

    Drug safety

    2010  Volume 33, Issue 8, Page(s) 631–642

    Abstract: Pregnant women with influenza are at increased risk of morbidity, particularly due to respiratory complications. A high excess mortality rate among pregnant women has been observed in previous influenza pandemics and healthcare agencies have provided ... ...

    Abstract Pregnant women with influenza are at increased risk of morbidity, particularly due to respiratory complications. A high excess mortality rate among pregnant women has been observed in previous influenza pandemics and healthcare agencies have provided recommendations on the use of oseltamivir to treat pregnant women who are infected with the pandemic (H1N1) 2009 virus. This article reviews pre-clinical and clinical data to assess the safety of oseltamivir administered during pregnancy, in the context of the effects of influenza on adverse pregnancy outcomes and fetal malformations. The effects of influenza during pregnancy, whether mediated directly by the virus or by fever or other events secondary to the underlying infection, are not yet well understood, but some data indicate an increased risk of birth defects in women infected with influenza during the first trimester. Animal and toxicology studies do not suggest that clinically effective dosages of oseltamivir have the potential to produce adverse effects on fetal development. Additionally, transplacental transfer of the drug and its active metabolite was very limited and not detectable at normal therapeutic doses in an ex vivo human placenta model. To investigate the safety of oseltamivir in pregnancy, the Roche oseltamivir safety database was searched for all exposures to oseltamivir during pregnancy in the 9 years up to 14 December 2008. In addition, a search of the literature was carried out. Of 232 maternal exposures to oseltamivir in the Roche database, pregnancy outcomes were known for 115 of these exposures. The incidence of adverse pregnancy outcomes was as follows: spontaneous abortions 6.1% (7/115), therapeutic abortions 11.3% (13/115) and pre-term deliveries 2.1% (2/94 live births), values that are not higher than background incidence rates. Fetal outcomes were known in 100 of the 232 exposures. For the nine cases of birth defect that were reported, the timing of oseltamivir exposure in relation to the sensitive period for inducing the birth defect was analysed. Two cases of ventricular septal defect, a more common birth defect, and one case of anophthalmos, an uncommon birth defect, were consistent with exposure to oseltamivir during the sensitive period for these birth defects. For other birth defects, there was either no exposure to oseltamivir during the sensitive period for the defect or insufficient information for assessment. These findings were consistent with other reports in the published literature, including a series of 79 Japanese women exposed to oseltamivir during the first trimester. Together with the other evidence reviewed herein, review of the company safety database suggests that oseltamivir is unlikely to cause adverse pregnancy or fetal outcomes, but available data are limited. Clinicians who use oseltamivir in pregnant women should consider the available safety information, the pathogenicity of the circulating influenza virus strain, the woman's general health and the guidance provided by health authorities. Roche will continue to monitor all reports of oseltamivir use during pregnancy.
    MeSH term(s) Animals ; Antiviral Agents/adverse effects ; Antiviral Agents/therapeutic use ; Drug Evaluation, Preclinical/methods ; Female ; Humans ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/enzymology ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Oseltamivir/adverse effects ; Oseltamivir/therapeutic use ; Pregnancy ; Pregnancy Complications, Infectious/epidemiology ; Pregnancy Complications, Infectious/prevention & control ; Pregnancy Outcome/epidemiology ; Prenatal Exposure Delayed Effects/chemically induced ; Prenatal Exposure Delayed Effects/epidemiology
    Chemical Substances Antiviral Agents ; Oseltamivir (20O93L6F9H)
    Language English
    Publishing date 2010-07-16
    Publishing country New Zealand
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1018059-x
    ISSN 1179-1942 ; 0114-5916
    ISSN (online) 1179-1942
    ISSN 0114-5916
    DOI 10.2165/11536370-000000000-00000
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Preparation and characterization of silver nanoparticle loaded amorphous hydrogel of carboxymethylcellulose for infected wounds

    Das, Anup / Ajay Kumar / Chandra Viswanathan / Deepa Ghosh / Niranjan B. Patil

    Carbohydrate polymers. 2015 Oct. 05, v. 130

    2015  

    Abstract: There is a growing demand for an appropriate and safe antimicrobial dressing to treat infected deep wounds. An amorphous gel formulation (SNP–CMC), containing silver nanoparticles (SNPs) and carboxymethylcellulose (CMC), was prepared in one step by the ... ...

    Abstract There is a growing demand for an appropriate and safe antimicrobial dressing to treat infected deep wounds. An amorphous gel formulation (SNP–CMC), containing silver nanoparticles (SNPs) and carboxymethylcellulose (CMC), was prepared in one step by the reduction of silver nitrate in situ. Spectrophotometric and microscopic analysis revealed that the SNPs were 7–21nm in diameter. In simulated wound experiments, SNP–CMC gel was found to absorb 80.48±4.69% w/w of saline and donate 17.43±0.76% w/w of moisture within 24h indicating its dual fluid affinity. Cytocompatibility of the gel was assessed by proliferation studies with primary human skin cells. The antimicrobial activity studies showed that SNP–CMC containing 50ppm of SNPs was effective against the growth of both Gram negative and Gram positive strains including methicillin-resistant Staphylococcus aureus (MRSA). These results indicate that SNP–CMC could be ideal for the treatment of deep infected wounds.
    Keywords antibiotic resistance ; anti-infective properties ; carboxymethylcellulose ; gels ; humans ; hydrocolloids ; methicillin ; methicillin-resistant Staphylococcus aureus ; nanosilver ; silver nitrate
    Language English
    Dates of publication 2015-1005
    Size p. 254-261.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 1501516-6
    ISSN 1879-1344 ; 0144-8617
    ISSN (online) 1879-1344
    ISSN 0144-8617
    DOI 10.1016/j.carbpol.2015.03.082
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  9. Article: Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data.

    Shanmugasundaram, Devika / Verma, Sanjay / Singh, Kuldeep / Dwibedi, Bhagirathi / Awasthi, Shally / Mahantesh, S / Singh, Himabindu / Santhanam, Sridhar / Mondal, Nivedita / S, Geetha / Sreenivasan, Priya / Malik, Shikha / Jain, Manish / Viswanathan, Rajlakshmi / Tripathi, Shalini / Patel, Bhupeshwari / Sapkal, Gajanan / Sabarinathan, R / Singh, Mini P /
    Ratho, R K / Nag, Vijaylakshmi / Gadepalli, Ravishekhar / Som, Tapas Kumar / Mishra, Baijayantimala / Jain, Amita / Ashok, M / Madhuri, Devara Sudha / Rani, V Sudha / Abraham, Asha Mary / John, Deepa / Dhodapkar, Rahul / Syed Ali, A / Biswas, Debasis / Pratyeke, Deepashri / Bavdekar, Ashish / Prakash, Jayant / Singh, Varsha / Prasad, Nidhi / Ray, Jaydeb / Majumdar, Agniva / Dutta, Shanta / Gupta, Nivedita / Murhekar, Manoj / Sharma, Akhil / Ghosh, Aniruddha / Alexander, Arun / Baranwal, Arun / Anantharaj, Avinash / Bethou, Adhisivam / Shekhawat, Dolat S / Kiruthika, G / Ram, Jagat / Gupta, Madhu / Gowda, Mamatha / Rohit, Manoj K / Dash, Nabaneeta / Sankhyan, Naveen / Kaushal, Nidhi / Shivanna, Niranjan Hunasanahalli / Kasturi, Nirupama / Kumar, P Prem / Gupta, Parul Chawla / Gunasekaran, Pradeep Kumar / Singh, Pratibha / Kumar, Praveen / Munjal, Sanjay Kumar / Agarwal, Siddharth / Manasa, Suhani / Shukla, Suruchi / Nehra, Urvashi / Verghese, Valsan P / Vyas, Varuna / Gupta, Vikas

    Heliyon

    2023  Volume 9, Issue 5, Page(s) e15965

    Abstract: Background: In India, facility-based surveillance for congenital rubella syndrome (CRS) was initiated in 2016 to estimate the burden and monitor the progress made in rubella control. We analyzed the surveillance data for 2016-2021 from 14 sentinel sites ...

    Abstract Background: In India, facility-based surveillance for congenital rubella syndrome (CRS) was initiated in 2016 to estimate the burden and monitor the progress made in rubella control. We analyzed the surveillance data for 2016-2021 from 14 sentinel sites to describe the epidemiology of CRS.
    Method: We analyzed the surveillance data to describe the distribution of suspected and laboratory confirmed CRS patients by time, place and person characteristics. We compared clinical signs of laboratory confirmed CRS and discarded case-patients to find independent predictors of CRS using logistic regression analysis and developed a risk prediction model.
    Results: During 2016-21, surveillance sites enrolled 3940 suspected CRS case-patients (Age 3.5 months, SD: 3.5). About one-fifth (n = 813, 20.6%) were enrolled during newborn examination. Of the suspected CRS patients, 493 (12.5%) had laboratory evidence of rubella infection. The proportion of laboratory confirmed CRS cases declined from 26% in 2017 to 8.7% in 2021. Laboratory confirmed patients had higher odds of having hearing impairment (Odds ratio [OR] = 9.5, 95% confidence interval [CI]: 5.6-16.2), cataract (OR = 7.8, 95% CI: 5.4-11.2), pigmentary retinopathy (OR = 6.7, 95 CI: 3.3-13.6), structural heart defect with hearing impairment (OR = 3.8, 95% CI: 1.2-12.2) and glaucoma (OR = 3.1, 95% CI: 1.2-8.1). Nomogram, along with a web version, was developed.
    Conclusions: Rubella continues to be a significant public health issue in India. The declining trend of test positivity among suspected CRS case-patients needs to be monitored through continued surveillance in these sentinel sites.
    Language English
    Publishing date 2023-05-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2023.e15965
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top